NIH Guide: Weekly Index for September 27, 2024

Funding Opportunities

• Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
  (PAR-24-299)
  National Institute on Drug Abuse
  Application Receipt Date(s): The referenced table includes NIH standard due dates marked with an asterisk.
• Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
  (PAR-24-300)
  National Institute on Drug Abuse
  Application Receipt Date(s): May 7, 2025
• NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
  (PAR-24-301)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
  (PAR-25-051)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Eye Institute
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed)
  (RFA-AI-24-065)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed)
  (RFA-CA-24-036)
  National Cancer Institute
  Application Receipt Date(s): December 2, 2024
• Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed)
  (RFA-DK-25-022)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 10, 2024
• National Evaluation Center (NEC) for AHRQs Healthcare Extension Service: State-based Solutions to Healthcare Improvement (U19)
  (RFA-HS-24-005)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): The application due date for this NOFO is November 25, 2024. No late applications will be accepted for this NOFO. All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• National Coordinating Center (NCC) for AHRQs Healthcare Extension Service - State-based Solutions to Healthcare Improvement (U54)
  (RFA-HS-24-006)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): The application due date is November 25, 2024. No late applications will be accepted for this NOFO. All applications are due by 5:00 PM local time of the applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
  (RFA-MH-25-200)
  National Institute of Mental Health
  Application Receipt Date(s): All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
  (RFA-MH-26-120)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional)
  (RFA-NR-25-001)
  National Institute of Nursing Research
  National Institute on Aging
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): December 13, 2024
• BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
  (RFA-NS-25-017)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
  (RFA-NS-25-018)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
  (RFA-NS-25-024)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): January 24, 2025